MIAMI, April 13, 2021 /PRNewswire/ -- eMed™, a digital health company democratizing healthcare through digital point-of-care solutions, today announced a partnership with Truepill™, the digital health ...
- First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes - Abbott and eMed™ expect to deliver and administer 30 ...
Quest Diagnostics Incorporated DGX recently entered into an agreement with telehealth company eMed in the field of COVID-19 testing. The deal with eMed, which has a digital-point-of-care solutions ...
MIAMI, Jan. 21, 2021 /PRNewswire/ -- eMed™, a digital health company democratizing healthcare through digital point-of-care solutions, today announced a partnership with the State of Ohio to ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The BinaxNOW COVID-19 Ag Card (Abbott) rapid antigen test for SARS-CoV-2 can now be used at home ...
The Food and Drug Administration (FDA) on Wednesday granted emergency use authorization for the cheapest at-home COVID-19 test yet, but consumers will need a prescription to obtain one. The BinaxNOW ...
A day after the U.S. Food and Drug Administration authorized the nation's first home COVID-19 test, the agency on Wednesday cleared a second home test made by Abbott Laboratories. Abbott said the ...
Getting your Trinity Audio player ready... Colorado teachers and school staff now have access to rapid, at-home COVID-19 testing to monitor their health during the spring semester as they await ...
Six companies are joining the effort to make home COVID-19 testing widely available. The White House plans to boost production of 60 million home tests by summer 2021. Lucira Health, Ellume, and ...
As COVID-19 cases surge across the U.S., there is growing demand for greater access to testing to rein in the pandemic. On Wednesday, the U.S. FDA granted an emergency use authorization (EUA) to ...
Abbott Laboratories in August won Food and Drug Administration emergency clearance for its portable test for the coronavirus strain Covid-19 that sells for just $5 and allow for “frequent mass testing ...
As COVID-19 cases surge across the U.S., there is growing demand for greater access to testing to rein in the pandemic. On Wednesday, the U.S. FDA granted an emergency use authorization (EUA) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback